Detecting and profiling molecular complexes

• US 8,198,031 B2
• Filed: 03/12/2007
• Issued: 06/12/2012
• Est. Priority Date: 08/11/2003
• Status: Expired due to Fees

• Current Assignee: Monogram Biosciences, Inc. (Laboratory Corporation Of America Holdings)
• Original Assignee: Monogram Biosciences, Inc. (Laboratory Corporation Of America Holdings)
• Inventors: Chan-Yui, Po-Ying, Singh, Sharat, Salimi-Moosavi, Hossein, Shi, Yining, Pidaparthi, Sailaja, Dua, Rajiv, Mukherjee, Ali
• Primary Examiner(s): Haq, Shafiqul
• Application Number:
  US11/717,760
• Publication Number:
  US 20080233602A1
• Time in Patent Office: 1,919 Days
• Field of Search: None
• US Class Current: 435/7.1
• CPC Class Codes: G01N 33/542 with steric inhibition or signal modification, e.g. fluorescent quenching
• CPC Class Codes: G01N 33/566 using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
• CPC Class Codes: Y10S 436/824 Immunological separation techniques

Abstract

Methods are provided for detecting the formation of complexes of molecules, especially proteins, in a sample, such as a cell or tissue lysate. In one aspect, a cleaving probe specific for a first protein in a complex and one or more binding compounds specific for one or more second proteins in a complex are provided. Upon binding, the cleaving probe is induced to generate an active species, such as singlet oxygen, that cleaves molecular tags attached to the binding compounds only in the local region of the cleaving probe. The released molecular tags are separated from the assay mixture and from one another to provide a readout that is related to the number and types of proteins present in the complex.

Claims

1. A method of detecting one or more complexes of proteins, wherein each complex comprises a first protein and one or more second proteins, the method comprising the steps of:

providing for each of the one or more complexes a cleaving probe specific for a first protein in each of the one or more complexes, each cleaving probe comprises a cleavage-inducing moiety attached to a binding agent that specifically binds to said first protein in each of the one or more complexes;

providing one or more binding compounds specific for a second protein of each of the one or more complexes, such that each binding compound comprises one or more molecular tags each attached to a binding moiety through a cleavable linkage, wherein said binding moiety specifically binds to said second protein of each of the one or more complexes, and such that the one or more molecular tags attached to different binding moieties have different separation characteristics so that upon separation molecular tags from different binding compounds form distinct peaks in a separation profile;

mixing the cleaving probes, the binding compounds, and the one or more complexes such that cleaving probes specifically bind to first proteins of the complexes and binding compounds specifically bind to the second proteins of the complexes such that the cleavable linkages of the binding compounds are within the effective proximity of the cleavage-inducing moieties of the cleaving probes so that the molecular tags are released; and

separating and identifying the released molecular tags to determine the presence or absence or the amount of one or more complexes of proteins.

2. The method of claim 1 wherein said step of mixing includes generating an active species by said cleavage-inducing moiety, the active species cleaving said cleavable linkages with said effective proximity.

3. The method of claim 2 wherein said cleavage-inducing moiety is a photosensitizer and said active species is singlet oxygen.

4. The method of claim 2 wherein said separation characteristics is electrophoretic mobility and wherein said separation profile is an electropherogram.

5. The method according to claim 4 wherein said one or more complexes of proteins comprise up to three complexes, and wherein said one or more binding compounds comprise up to three binding compounds.

6. The method of claim 5 wherein each of said cleaving probes and said one or more binding compounds comprises an antibody binding composition.

7. The method of claim 6 wherein said one or more complexes includes a complex comprising an IGF1 receptor and an IRS1.

8. The method of claim 7 wherein said IGF1 receptor is said first protein whenever said IRS1 is said second protein, and wherein said IRS1 is said first protein whenever said IGF1 receptor is said second protein.

17. The method of claim 6 wherein said one or more complexes includes a complex comprising SHC and GRB2.

18. The method of claim 17 wherein said SHC is said first protein whenever said GRB2is said second protein, or wherein said GRB2is said first protein whenever said SHC is said second protein.

19. The method of claim 6 wherein said one or more complexes includes a complex comprising a PI3kinase and an IRS1.

20. The method of claim 19 wherein said PI3 kinase is said first protein whenever said IRS 1 is said second protein, or wherein said IRS1is said first protein whenever said PI3kinase is said second protein.

25. The method of claim 6 wherein said one or more complexes includes a complex comprising SHC and Her3.

26. The method of claim 25 wherein said SHC is said first protein whenever said Her3 is said second protein, or wherein said Her3 is said first protein whenever said SHC is said second protein.

9. A method of detecting in a biological sample a complex comprising a first protein and one or more second proteins, the method comprising the steps of:

providing a cleaving probe specific for an antigenic determinant of the first protein, the cleaving probe having a cleavage-inducing moiety attached to a binding agent that specifically binds to said antigenic determinant of the first protein;

providing one or more binding compounds each specific for an antigenic determinant of the second protein, such that each binding compound comprises one more molecular tags each attached to a binding moiety through a cleavable linkage, wherein said binding moiety specifically binds to said antigenic determinant of the second protein, and such that the one or more molecular tags attached to different binding moieties have different separation characteristics so that upon separation molecular tags from different binding compounds form distinct peaks in a separation profile;

mixing the cleaving probe, the one or more binding compounds, and the biological sample such that cleaving probes specifically binds to first protein and the one or more binding compounds specifically bind to the one or more second proteins, and such that the cleavable linkages of the binding compounds are within the effective proximity of the cleavage-inducing moieties of the cleaving probes so that the molecular tags are released; and

separating and identifying the released molecular tags to determine the presence or absence or the amount of complex in the biological sample.

10. The method of claim 9 wherein at least one of said second proteins is different than said first protein.

11. The method of claim 10 wherein said step of mixing includes generating an active species by said cleavage-inducing moiety, the active species cleaving said cleavable linkages with said effective proximity.

12. The method of claim 11 wherein said cleavage-inducing moiety is a photosensitizer and said active species is singlet oxygen.

13. The method of claim 11 wherein said separation characteristics is electrophoretic mobility and wherein said separation profile is an electropherogram.

14. The method according to claim 13 wherein said cleaving probe and said one or more binding compounds each comprise an antibody binding composition.

15. The method of claim 14 wherein said complex comprises an IGF1 receptor and an IRS1.

16. The method of claim 15 wherein said IGF1receptor is said first protein whenever said IRS1is said second protein, or wherein said IRS1is said first protein whenever said IGF1receptor is said second protein.

21. The method of claim 14 wherein said one or more complexes includes a complex comprising SHC and GRB2.

22. The method of claim 21 wherein said SHC is said first protein whenever said GRB2 is said second protein, or wherein said GRB2 is said first protein whenever said SHC is said second protein.

23. The method of claim 14 wherein said one or more complexes includes a complex comprising a PI3 kinase and an IRS1.

24. The method of claim 23 wherein said PI3kinase is said first protein whenever said IRS1 is said second protein, or wherein said IRS1 is said first protein whenever said PI3 kinase is said second protein.

27. The method of claim 14 wherein said one or more complexes includes a complex comprising SHC and Her3.

28. The method of claim 27 wherein said SHC is said first protein whenever said Her3 is said second protein, or wherein said Her3 is said first protein whenever said SHC is said second protein.